                               NBER WORKING PAPER SERIES




                                 MONEYBALL IN MEDICARE

                                        Edward C. Norton
                                            Jun Li
                                           Anup Das
                                         Lena M. Chen

                                       Working Paper 22371
                               http://www.nber.org/papers/w22371


                     NATIONAL BUREAU OF ECONOMIC RESEARCH
                              1050 Massachusetts Avenue
                                Cambridge, MA 02138
                                     June 2016




This work was supported by the National Institute on Aging (P01-AG019783). Emmett Keeler
and Elena Prager provided helpful conference discussions. We are grateful for comments by
seminar participants at the London School of Economics, the University of Chicago, the
University of Michigan, and ASHEcon. The views expressed herein are those of the authors and
do not necessarily reflect the views of the National Bureau of Economic Research.

At least one co-author has disclosed a financial relationship of potential relevance for this
research. Further information is available online at http://www.nber.org/papers/w22371.ack

NBER working papers are circulated for discussion and comment purposes. They have not been
peer-reviewed or been subject to the review by the NBER Board of Directors that accompanies
official NBER publications.

Â© 2016 by Edward C. Norton, Jun Li, Anup Das, and Lena M. Chen. All rights reserved. Short
sections of text, not to exceed two paragraphs, may be quoted without explicit permission
provided that full credit, including Â© notice, is given to the source.
Moneyball in Medicare
Edward C. Norton, Jun Li, Anup Das, and Lena M. Chen
NBER Working Paper No. 22371
June 2016
JEL No. I11,I13,I18

                                         ABSTRACT

US policymakers place a high priority on tying Medicare payments to the value of care delivered.
A critical part of this effort is the Hospital Value-based Purchasing Program (HVBP), which
rewards or penalizes hospitals based on their quality and episode-based costs of care. Within
HVBP, each patient affects hospital performance on a variety of quality and spending measures,
and performance translates directly to changes in program points and ultimately dollars. In short,
hospital revenue from a patient consists not only of the DRG payment, but also consists of that
patientâ€™s marginal future reimbursement. We estimate the magnitude of the marginal future
reimbursement for individual patients across each type of quality and performance measure. We
describe how those incentives differ across hospitals, including integrated and safety-net
hospitals. We find some evidence that hospitals improved their performance over time in the
areas where they have the highest marginal incentives to improve care.


Edward C. Norton                                       Anup Das
Department of Health Management                        Department of Health Management
 and Policy                                             and Policy
Department of Economics                                University of Michigan
University of Michigan                                 School of Public Health
School of Public Health                                1415 Washington Heights, M3108 SPHII
1415 Washington Heights, M3108 SPHII                   Ann Arbor, MI 48109-2029
Ann Arbor, MI 48109-2029                               anupdas@med.umich.edu
and NBER
ecnorton@umich.edu                                     Lena M. Chen
                                                       Department of Internal Medicine
Jun Li                                                 University of Michigan
Department of Health Management                        Ann Arbor, MI 48109-2029
  and Policy                                           lenac@med.umich.edu
University of Michigan
School of Public Health
1415 Washington Heights, M3108 SPHII
Ann Arbor, MI 48109-2029
lijununi@umich.edu
1. Introduction

       The Centers for Medicare and Medicaid Services (CMS) and other large payers are

increasingly using value-based purchasing programs to motivate better quality and more efficient

care. The Hospital Value-Based Purchasing (HVBP) program is one of the largest mandatory,

value-based purchasing programs and is central to the US governmentâ€™s effort to tie 85% of fee-

for-service Medicare payments to quality or value by 2016 (Burwell, 2015). Unlike other

initiatives, CMSâ€™s Hospital Value-Based Purchasing (HVBP) program explicitly ties financial

incentives to hospital performance on both quality and episode payments. Additionally, the

HVBP program affects future hospital revenue based on prior performance, creating financial

incentives to improve performance.

       An ongoing concern of HVBP and other pay-for-performance programs is that it is

unclear whether the size of the incentives is adequate to induce hospital behavior change (Ryan

et al., 2015; Figueroa et al, 2016). To better understand why the evidence suggests that hospitals

are not improving their performance in some measures, a closer characterization of the incentives

each hospital faces is needed. This paper describes the HVBP incentives faced by hospitals,

estimates their magnitude and distribution, and tests whether hospitals facing larger financial

incentives are more likely to improve performance.

       For the roughly 3,000 hospitals in the program, performance on quality and spending

metrics in the current year affects Medicare payments in future years (Centers for Medicare &

Medicaid Services, 2012a). For example, in Fiscal Year (FY) 2016, the program adjusted

Medicare payments to hospitals by as much as two percent, up or down, based on performance

mostly in FY 2014 (Centers for Medicare & Medicaid Services, 2013a). For each participating

hospital, their financial bonus or penalty is determined by their relative performance across a



                                                 2
variety of measures spanning four domains: patient experience, clinical process of care,

outcomes, and efficiency (Centers for Medicare & Medicaid Services, 2013a). The efficiency

domain is comprised of a single measure of Medicare Part A and Part B spending during an

episode of care (Das et al., 2016a).

       The HVBP program has created two fundamental changes in Medicare hospital

reimbursement. Because each Medicare patient affects hospital performance on a variety of

quality and spending measures, each patientâ€™s care and outcomes translate directly to changes in

program points and ultimately dollars. For example, spending during a single episode of care ï£§

including in a skilled nursing facility, outpatient rehabilitation, home health care, and

readmission to a hospital ï£§ affects a hospitalâ€™s total episode spending measure. Hospital

performance across all the quality and spending measures determines the magnitude of the

change in the base-operating DRG amount a hospital will receive for patients in a future fiscal

year. Hospitals that perform well in both spending and quality measures receive the largest

bonuses (Das et al., 2016b). In short, hospital revenue from a given patient consists not only of

the current Diagnosis related Group (DRG) payment as has been the case in traditional fee-for-

service Medicare, but also consists of that patientâ€™s marginal future reimbursement due to that

patientâ€™s marginal effect on the HVBP bonus or penalty.

       The HVBP program also has extended the relevant timeframe for performance to a 30-

day episode that starts three days prior to admission and ends 30 days after discharge. Hospitals

have financial incentives to improve quality and lower spending for the entire episode of care,

including care supplied by other providers up to 30 days post discharge. As a result, hospitals

may seek ways to integrate with providers of post-acute care.




                                                  3
       The HVBP programâ€™s incentives have several implications for hospital behavior. First,

hospitals have incentives to improve many aspects of quality of care and to reduce episode

spending. Second, because these incentives vary widely ï£§ from zero at the margin to quite

large financial incentives, depending on where the hospitals are in the performance distribution

compared to other hospitals and their own baseline measures ï£§ different hospitals have vastly

different incentives to make improvements in spending or in different quality domains.

Therefore, we expect hospitals to respond to their own incentives at the margin, and make

improvements in different areas in the future. Third, we expect that hospitals that have already

integrated with post-acute care providers will perform better, and that some hospitals will have

strong incentives to integrate more with post-acute care providers.

       Because hospitals are now being held accountable for the quality and cost of care given

by other providers, there are incentives to increase integration with post-acute care providers

such as skilled nursing facilities, inpatient rehabilitation facilities, and home health care agencies

(Chen and Ackerly, 2014). For example, hospitals can improve integration with skilled nursing

facilities through mergers, acquisitions, or informal contracts. With the addition of the episode

spending measure to the program, CMS hoped it would increase the incentives for hospitals to

engage in care coordination with other provider (Centers for Medicare & Medicaid Services,

2012b). The HVBP program is especially important for the movement towards more integration

because, unlike the ACO and bundled payment programs that are for the most part voluntary, the

HVBP applies to almost all general hospitals.

       After describing the HVBP program and incentives, the empirical work has three parts.

First, we quantify the marginal incentives for a change in mortality by one and the incentives for

an improvement in all measures by one decile. We not only calculate the mean, but document


                                                  4
the wide heterogeneity in incentives that typically include many zeros and a long right tail.

Second, we describe the heterogeneity in those incentives across hospitals, including by whether

the hospital is integrated with post-acute care providers. Third, we test whether hospitals with

larger marginal incentives to improve respond with larger changes in those measures from FY

2015 to FY 2016. We predict that hospitals respond to those incentives by improving their score

on the domains that have the greatest potential payoff.

       We use national data on about 3,000 hospitals to compute the effect of a one decile

improvement in each of the measures. Using the FY 2016 performance data we can see how

hospitals changed their domain scores as a function of the marginal incentives. In addition, we

have patient-level data for all Michigan Medicare patients from FY 2015. From those Michigan

data we compute the effect of a change in mortality by one death on future Medicare payments.



2. Hospital Value-Based Purchasing

       The Hospital Value-Based Purchasing (HVBP) program financially incentivizes hospitals

to improve their performance across a variety of measures every fiscal year. As legislated by the

Affordable Care Act, the HVBP program is managed by the Center for Medicare and Medicaid

Services (CMS). This program applies to all acute care hospitals that participate in the Inpatient

Prospective Payment System, with some minor exclusion criteria (Centers for Medicare &

Medicaid Services, 2013b). Around 3,000 acute care hospitals participated in FY 2015.

       Although the program has gone through several changes since it first was implemented in

FY 2013, the basic structure of the program has remained constant (Centers for Medicare &

Medicaid Services, 2013a). Hospital performance across a defined set of measures within

broader categorical domains is collected, scored, and weighted, leading to an overall program



                                                 5
score which is translated into a financial bonus or penalty. The bonus or penalty is a percentage

point increase or decrease in a hospitalsâ€™ base-operating DRG payment amount, which is used in

the Medicare Inpatient Prospective Payment System. Accordingly, the motivation behind the

program is that hospitals can avoid a reduction in their base DRG payment amount by

performing well on the included measures. This program is financed by an initial base-operating

DRG payment reduction for all participating hospitals each fiscal year. Starting in FY 2013,

there was a 1.0 % reduction to fund the incentive payments, and subsequently the maximum

penalty or bonus was approximately 1.0%. In subsequent years, this amount has increased by

0.25%, plateauing at 2.0% from FY 2017 onwards. The HVBP program is designed to be budget

neutral. Therefore, it redistributes payments from hospitals with measured low quality of care

and high episode spending to those that perform well on those measures.

       In FY 2013, the two domains of measures were patient experience of care, which

accounted for 30% of the overall program score, and clinical process of care, which accounted

for 70% (see Table 1). The patient experience of care domain consists of measures drawn from

the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey,

while the clinical process of care domain includes medical and surgical process of care measures

(Centers for Medicare & Medicaid Services, 2013a). In FY 2014, the program added an

outcomes domain, composed of 30-day mortality rates for acute myocardial infarctions, heart

failure, and pneumonia. This new domain accounted for 25% of the overall program score,

while the clinical process of care domain weight was decreased to 45% (see Table 2 for details

about measures within domains).

       In FY 2015, the program added an efficiency domain, which consisted of only one

measure, the Medicare-Spending-per-Beneficiary. This is a measure of hospitalization episode



                                                6
costs, including Medicare Part A and Part B spending from three days before an index hospital

admission through 30 days post-discharge (Quality Net, 2015). In addition to this new domain,

there were some changes to the measures in the clinical process of care and outcome domains.

The efficiency and clinical process of care domains each accounted for 20% of the overall

program score in FY 2015, while the patient experience of care and outcome domain each

accounted for 30% (Centers for Medicare & Medicaid Services, 2013a). There are no new

domains for the program in FY 2016, but there were changes to the measures in the clinical

process of care and outcome domains, as well as the overall domain weighting (see Table 1 for a

comparison of the domain weights over years).

       The HVBP program scores hospitals based on their achievement (comparison to other

hospitals), as well as their improvement (comparison to their own previous performance). Every

fiscal year of the program has an affiliated performance period and baseline period that vary

across measures (Centers for Medicare & Medicaid Services, 2013b). Generally, each

performance period initiates approximately two years prior to the fiscal year for which payment

adjustments take effect to ensure that CMS has sufficient time to collect and process the data.

These dates are set well in advance by the federal government so that hospitals are able to

engage in efforts to improve their performance. In all measures besides the Medicare-Spending-

per-Beneficiary measure, hospital achievement points are assigned by comparing hospital

performance during the performance period to the performance of all other hospitals in the

baseline period. In the spending measure, achievement points are assigned by comparing hospital

rates to all other hospital rates, with both rates drawn from the performance period.




                                                 7
        The specific conversion of measures to achievement points depends on several

distributions. If a hospitalâ€™s rate is better than or equal to the mean of the highest performing

decile, they receive 10 points, and if a hospitalâ€™s rate is worse than the median, they receive 0

points. When a hospitalâ€™s rate is better than or equal to the median and worse than the mean of

the top decile, they receive a score between 0 and 10, depending on their rate, the median, and

the mean of the best decile (Centers for Medicare & Medicaid Services, 2013b). Hospital

improvement points are awarded by comparing a hospitalâ€™s rates during the performance period

to the same hospitalâ€™s rates during the baseline period. If a hospitalâ€™s performance has declined,

they receive 0 points, if it is better than the mean of the best decile, they receive 9 points, and if it

is in between, they receive a score between 0 and 9, depending on their performance period rate,

their baseline rate, and the mean of the best decile. The patient experience of care also assigns

hospitals consistency points, which gives hospitals 20 points for being above the median in all

eight survey dimensions included in the domain, or else they receive a score depending on their

performance, the median, and the lowest score (Centers for Medicare & Medicaid Services,

2013a).

        The highest of either the achievement or improvement score is awarded to each hospital

for every measure, as long as the hospital has met the required minimum number of cases for

each measure (Centers for Medicare & Medicaid Services, 2013b). In the patient experience of

care domain, the consistency score is added with a base score to determine the overall domain

score (Centers for Medicare & Medicaid Services, 2013a). Summing the scores across all the

measures within each domain, and dividing by the total possible points in each domain provides

a normalized score that is subsequently weighted according to CMS-specified domain weights.

The sum of the domain scores results in an overall program score labeled the Total Performance



                                                   8
Score (TPS). This score is then translated into an incentive bonus (or penalty) with a linear

exchange function (Centers for Medicare & Medicaid Services, 2013b). We will refer to the

incentive payment as a bonus, without loss of generality. Ultimately this bonus affects future

Medicare reimbursement for inpatient care for an entire year. Therefore, changes in measured

quality and episode payments affect future Medicare reimbursement.

       The design of the HVBP program is a principal-agent problem with multitasking, where

CMS is the principal and hospitals (Holmstrom and Milgrom, 1991). Concerns about this pay-

for-performance program are similar to concerns in education, where increasingly teachers and

even students face strong financial incentives for achievement on specific tests. Those concerns

include creating incentives that are too weak to illicit a response and teaching to the test (see

Neal (2011) for a review of the literature). The results on whether holding teachers accountable

improves student performance are decidedly mixed (Jacob, 2005; Fryer, 2013). As with

education, it is an open empirical question whether CMSâ€™s HVBP program induces the desired

positive improvements in patient outcomes.



3. Economic Incentives in HVBP

Marginal future reimbursement

       We discuss the HVBP formulas in great detail to understand theoretically how changes in

one patientâ€™s performance measures affect future Medicare payments. We also explain how

those incentives are nonlinear for a given hospital and therefore heterogeneous across hospitals,

creating heterogeneous incentives for improvement.

       Our primary theoretical point is that Medicare payment for one patient hospitalization is

no longer just the diagnosis related group (DRG) payment, as it was prior to HVBP, but now also



                                                  9
includes a marginal future reimbursement. Simply put, hospital jâ€™s Medicare reimbursement for

patient i is the sum of their current DRG payment plus the discounted marginal future

reimbursement (discounted two years at discount rate Î´ per year).

         Total Reimbursementij = Current DRGij + Î´2Ã—(Marginal Future Reimbursementij) (1)

       The first term on the right-hand side of equation (1) represents the payment by Medicare

to the hospital for the patientâ€™s index hospitalization, based on the DRG. The DRG payments

vary across hospitals due to a variety of adjustments such as for teaching status, disproportionate

share hospital (DSH) payments, and geographic variation in cost of living adjustments. This

explains the hospital subscript j in equation (1). Of course, our theoretical point only applies to

Medicare patients and to hospitals that participate in the HVBP program.

       The second term is the focus of this paper. Unlike the DRG, the marginal future

reimbursement is not uniform for all patients at the same hospital with the same medical

condition and treatment. Instead, it varies by patient within hospital for each of the four domains

of patient experience, clinical processes, outcomes, and episode payments. It varies across

hospitals for otherwise identical patients because the marginal incentives differ depending on

where a hospital is in the distribution of performance levels within each of these measures.

       For example, consider two patients admitted to the same hospital for coronary bypass

with percutaneous transluminal coronary angioplasty (PTCA) but without major complications.

Both will be assigned to DRG 232. The hospital receives the same DRG payment for their index

hospitalization. However, suppose one dies shortly after discharge while the other lives. The

patient who dies will raise the hospitalâ€™s mortality rate, adversely affecting the hospitalâ€™s

outcome domain, percent bonus, and future Medicare payments, while the patient who lives

improves the hospitalâ€™s mortality rate. The two patients have different marginal future


                                                 10
reimbursements, one positive and one negative, solely based on their mortality. About two years

in the future, all Medicare payments for that hospital will be affected by the mortality rate in the

current year, resulting in a discounted (by Î´2 over two years) adjustment to the percent bonus that

is applied to all Medicare payments for inpatient care. A similar story can be told about the other

measures of quality of care and episode payments.

       In contrast, consider two identical patients who have identical experiences in terms of all

the measured outcomes, yet are admitted to different hospitals. Although their experiences are

the same, they could have quite different marginal future reimbursements. For example, if one

hospital is already a top performer and has the maximum number of achievement points, the

marginal future reimbursements will be zero. A hospital that is in the upper-middle part of the

distribution will typically have larger marginal future reimbursements. There is heterogeneity in

the marginal future reimbursement across hospitals as well as within hospitals.

       Next we focus on the details of the HVBP program, to understand the translation from

specific measures to dollars. The conversion of measures to dollars has four steps. The

measures are converted to points. The Total Performance Score (TPS) is the weighted sum of

points. The percent bonus is a rescaling of TPS. The intent was to have a range from â€“1.5 to

1.5% in FY 2015, but the actual numbers were from â€“1.24% to 2. 09%, resulting in a budget-

neutral redistribution. Finally, the percent bonus is applied to each hospitalâ€™s future Medicare

inpatient payments.

              Measures â†’ Points â†’ TPS â†’ % Bonus â†’ $                                          (2)

       Every measured outcome ï£§ the 12 clinical processes of care, eight patient experience

scores, five patient health outcomes, and one episode payment (in fiscal year 2015) ï£§ affects

future Medicare reimbursement. The marginal effect of one patient on future Medicare


                                                 11
reimbursement, summed over the 26 different measures, depends on five partial derivatives. The

marginal future reimbursement (MFR) is specific to each patient i and their hospital j.

                    ðœ•$
  ð‘€ð¹ð‘…ð‘– = E ï¿½               ï¿½                                                               (3)
                 ðœ•ð‘ƒð‘Žð‘¡ð‘–ð‘’ð‘›ð‘¡ð‘–

    The marginal future reimbursement for each patient is the full partial derivative summed

over all 26 measures.
            26
             ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘š    ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—   ð‘‘ð‘‡ð‘ƒð‘†ð‘—     ð‘‘%ðµð‘œð‘›ð‘¢ð‘      ð‘‘$
 ð‘€ð¹ð‘…ð‘– = ï¿½ E ï¿½           Ã—           Ã—         Ã—         Ã—         ï¿½ (4)
              ð‘‘ð‘ƒð‘Žð‘¡ð‘–ð‘’ð‘›ð‘¡ð‘šð‘– ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘— ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—    ð‘‘ð‘‡ð‘ƒð‘†     ð‘‘%ðµð‘œð‘›ð‘¢ð‘ 
           ð‘š=1

    Because the conversion of TPS to percent bonus to dollars is independent of the specific

measures, we can rearrange the formula by pulling out the last two terms. Furthermore, the

expectation operator matters only for the change in points from the change in measures, which is

actually discontinuous because of rounding but we analyze as if it were continuous.
                               26
                                     ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘—        ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—      ð‘‘ð‘‡ð‘ƒð‘†ð‘—
                  ð‘€ð¹ð‘…ð‘– = ï¿½ ï¿½                     Ã— Eï¿½            ï¿½Ã—           ï¿½
                                      ð‘‘ð‘ƒð‘Žð‘¡ð‘–ð‘’ð‘›ð‘¡ð‘šð‘–      ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘—    ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—
                               ð‘š=1

                                          ð‘‘%ðµð‘œð‘›ð‘¢ð‘ ð‘—     ð‘‘$ð‘—
                                     Ã—ï¿½            Ã—          ï¿½ (5)
                                           ð‘‘ð‘‡ð‘ƒð‘†ð‘—     ð‘‘%ðµð‘œð‘›ð‘¢ð‘ ð‘—

       Working backwards through equation (5), the effect of the percent bonus on a hospitalâ€™s

annual Medicare reimbursement (% Bonus â†’ $) depends on annual Medicare inpatient

payments. In other words, it is roughly proportional to hospital size. The amount of the bonus

(in dollars) is the percent bonus multiplied by the inpatient Medicare payments in a year. The

total annual Medicare inpatient payments will be proportional to the number of Medicare

inpatients, and may be many tens of millions of dollars. Therefore, even a miniscule change in

the percent bonus can lead to a substantial change in dollars.




                                                    12
       The conversion of TPS to percent bonus (TPS â†’ % Bonus) is perfectly linear. In FY

2015, the conversion was 2.5801048882. This maps the range of TPS (from 6.6 to 92.86 in FY

2015) into the percent bonus range of â€“1.24% to 2.09%. The conversion factor differs by year.

Similarly, the conversion of measures to points to TPS (Points â†’ TPS) is also linear, although

the weights have changed over the years (as explained in section 2).

       Finally, the conversion of the raw measures to points (Measures â†’ Points) is complex

and nonlinear. It depends on the hospitalâ€™s score relative to other hospitals and to its own

baseline score. For an excellent hospital, a small marginal improvement will not lead to any

more points. For a bad hospital, a small marginal improvement will not lead to any achievement

points, but may (or may not) generate improvement points. Because this part of the formula is

too complicated to summarize in a single formula, we will rely on empirical data to determine

the average marginal effects at different points in the distribution, averaged across different

hospitals and different domains.



Implications

       This conceptual framework has several implications. First, each Medicare patient has a

marginal future reimbursement which contributes to their total reimbursement. Each patient

contributes to at least some of the measures used to determine the percent bonus. (For example,

although all Medicare patients are included in the efficiency score, only AMI, heart failure, and

pneumonia patients affect the mortality score, only some patients are measured for patient

experience.) Each patient changes the hospitalâ€™s measures, which ultimately affects that

hospitalâ€™s future Medicare reimbursement.




                                                 13
       Second, the relationship between one patientâ€™s measures and future hospital

reimbursement is complicated and nonlinear. However, we can glean some insights from the

formulas. If a patientâ€™s measures are better than the hospitalâ€™s average, then the marginal benefit

is positive. If the patientâ€™s measures are worse than the hospitalâ€™s average, then the marginal

future reimbursement is negative. If the patientâ€™s measures are sufficiently poor, then the

marginal future reimbursement could be negative enough to dominate the DRG payment, leaving

the hospital with a net negative reimbursement for that patient. Hospitals in the middle of the

distribution for a measure will have larger marginal effects than those at either extreme.

Hospitals with many Medicare patients have more money at stake, but any one patient has a

smaller marginal effect on the percent bonus. These effects roughly cancel out, because the

marginal effects are multiplicative and one is proportional to number of patients and the other is

inversely proportional.

       Third, there is great heterogeneity in these effects, both across patients within hospitals

and across hospitals. Within a hospital, there is heterogeneity across patients because some

patientsâ€™ measures will improve the hospital average and other patientsâ€™ measures will worsen

the hospital average. Of course, most patients will have some measures above and some below.

There is also heterogeneity across Medicare patients in how many measures will be taken for

each patient. As discussed above, certain measures only apply to patients with certain medical

conditions, or those who take the patient experience survey. Between hospitals there is

heterogeneity in their baseline measures and where their average is in the overall distribution,

and those differences create nonlinearities in the marginal effects.

       Fourth, the marginal future reimbursements create incentives for hospitals to improve

their quality and episode payments for care. Furthermore, each hospital can determine which



                                                 14
areas of quality improvement have the highest return on investment. Those are the areas where

the hospital should invest (assuming that the cost of effort is equal across domains). However,

some hospitals have zero marginal incentive to improve, as we will show.

       Fifth, hospitals that have already integrated with some post-acute care providers should

have lower cost of improving quality of care, due to shared information, resources, and goals.

Therefore, hospitals that have already integrated may exhibit greater improvement in their

measures from one year to the next, due to the lower cost of improvement.

       The conceptual framework also guides our empirical research. One empirical goal is

descriptive: to estimate the magnitude of these incentives, to show the distribution across

hospitals, and to explain how it varies across hospitals. We estimate the magnitudes of the

marginal future reimbursements at the patient level for certain measures, and the average

marginal future reimbursement for modest changes at the hospital level, to see how large these

incentives are. We are interested in the distributions, not merely the means, including the

fraction of zeros and the maximum. We want to know if the distributions vary across different

measures, and systematically by hospital characteristics such as size, integration, and safety-net

status. Another empirical goal is behavioral: to estimate whether hospitals actually respond to

these incentives by improving most in domains where they have the largest margin for

improvement. We test to see if the observed changes in measures from year to year are

positively related to the average hospital-level incentive for improvement. If yes, then that

indicates that the current financial incentives in HVBP are enough to promote the desired

improvement (although that alone will not indicate if the magnitude is optimal).




                                                15
4. Empirical work

MFR for mortality in Michigan

       One way to measure the effect of mortality is to ask: by how much would marginal

future reimbursements change if one more patient had died? We ask the question this way,

instead of one fewer, because mortality rates are low, so adding one death avoids any floor

effects. The approach is straightforward. We know the total number of patients in a hospital

who were treated for acute myocardial infarction (AMI), heart failure, or pneumonia during the

measurement period. We know the observed mortality rate. Therefore, we can estimate the

number of deaths (the estimated number may not be an exact integer due to small differences in

sample between our sample derived directly from Medicare claims and what CMS uses). Then

we recalculate the mortality rate as if one more person had died. Next, we recalculate

achievement and improvement points for that hospital, which then changes the total performance

score, percent bonus, and total dollars. For some hospitals, especially those near the top and

bottom of the mortality distribution, one additional death will have no effect on their points or

marginal future reimbursement. Therefore, for each of the three measured mortality rates (m =

AMI, heart failure, pneumonia), we estimate a modification of equation (5).

             ð‘‘ð‘€ð‘œð‘Ÿð‘¡ð‘…ð‘Žð‘¡ð‘’ð‘šð‘—     ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—      ð‘‘ð‘‡ð‘ƒð‘†ð‘—     ð‘‘%ðµð‘œð‘›ð‘¢ð‘ ð‘—     ð‘‘$ð‘—
 ð‘€ð¹ð‘…ð‘šð‘— =                 Ã—Eï¿½           ï¿½Ã—           Ã—          Ã—          (6)
              ð‘‘1ð‘‘ð‘’ð‘Žð‘¡â„Žð‘šð‘—     ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘—    ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—    ð‘‘ð‘‡ð‘ƒð‘†ð‘—     ð‘‘%ðµð‘œð‘›ð‘¢ð‘ ð‘—

       One important technical note is that we allow for fractional changes in achievement and

improvement points. This does not happen when CMS assigns points; CMS rounds all points to

the nearest integer. Our approach is consistent with an expected increase. Because these

measures are too complicated to game precisely, we feel that our approach gives a better sense of

the actual marginal future reimbursement.



                                                16
One-decile improvement

       While the analysis looking at a change in a single patientâ€™s outcome is revealing, the

more policy-relevant approach estimates the effect on future reimbursement if a hospital makes a

modest improvement in one measure. Hospitals often embark on initiatives to improve quality

or to lower episode spending in certain departments or for specific medical conditions.

Therefore it is natural to ask, what is the effect of a one-decile improvement in a measure on

future Medicare reimbursement? A one-decile improvement in a measure is more standardized

across measures than a one-unit improvement, it is large enough to be meaningful, and it is

roughly equal to the mean improvement for hospitals that do improve. Such a question can be

answered without individual data. Because we know each hospitalâ€™s score for each of the 26

measures in the four domains, we can simulate what would happen if that measure improved by

one decile. For those in the top decile, we simulate them moving to the top of the distribution.

We chose a one-decile improvement because it is standardized across different measures and is

large enough to be a meaningful change.

       In this way, we can estimate the effect of a modest improvement in each measure. For

example, a hospital at the 24th percentile improves to the 14th percentile. Given the change in

measure, we can estimate the change in achievement and improvement points, which leads to

improvements in TPS, percent bonus, and dollars. Although all hospitals in this simulation will

improve their measure, the change in dollars may be small if there is no corresponding change in

points. Therefore, for each of the 26 measures, we estimate a modification of equation (5).

             ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘—        ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—      ð‘‘ð‘‡ð‘ƒð‘†ð‘—     ð‘‘%ðµð‘œð‘›ð‘¢ð‘ ð‘—     ð‘‘$ð‘—
  ð‘€ð¹ð‘…ð‘šð‘— =                Ã— Eï¿½            ï¿½Ã—           Ã—          Ã—          (7)
              ð‘‘1ð‘‘ð‘’ð‘ð‘–ð‘™ð‘’ð‘šð‘—      ð‘‘ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘—    ð‘‘ð‘ƒð‘œð‘–ð‘›ð‘¡ð‘ ð‘šð‘—    ð‘‘ð‘‡ð‘ƒð‘†ð‘—     ð‘‘%ðµð‘œð‘›ð‘¢ð‘ ð‘—




                                                17
Heterogeneity in one-decile improvement

       We explored which hospitals tend to fall in which parts of the distribution of the marginal

future reimbursements. This was done two ways. The first way provided a technical exploration

of the nonlinear relationship between the measures and the marginal future reimbursement. We

expected, for example, that hospitals at the bottom and at the top of the distribution of measure

would have the smallest marginal future reimbursements. We graphed the mean change in TPS

as a function of the achievement points and the improvement points. The helped illustrate how

the formulas work, and how the measures translate to changes in TPS. In other words, which

hospitals face the highest and lowest incentives to improve because of there their measured

quality is within the distribution of achievement and improvement points.

       The second way explored how hospital characteristics (integration, teaching status, size,

safety-net, urban/rural, etc.) are related to the incentives. This showed which kinds of hospitals

face the strongest incentives. Similar work has been done in terms of the total amount of money

paid in bonuses; we extended that research to the underlying incentives. Together, these two sets

of analyses provided important information.



Change in TPS

       Our conceptual framework predicts that having a stronger financial incentive to improve

should be associated with a greater year-to-year improvement in that measure. Therefore, we

will run regressions to predict the change in measure performance (from FY 2015 to FY 2016)

on the size of the marginal incentive. We operationalize this by using the calculated one-decile

improvement in the TPS score. A one-decile improvement standardizes improvements across




                                                18
different measures. Certainly hospitals may improve by more (or less) than one decile, but this

standardizes the amounts.

        Our basic model predicts the change in a measure m over two years in hospital j as a

function of the marginal TPS score in the first year (due to a one-decile change in the measure).

Because the marginal TPS score measures the incentive for improving, we expect that the

coefficient on marginal TPS will be positive. The model has one observation per hospital.

Hospital-level control variables (X) include the value-based purchasing adjustment factor in FY

15, percent of Medicare days, teaching affiliation, number of beds, for-profit status, and the

integration status and safety-net status.

          âˆ†ð‘€ð‘’ð‘Žð‘ ð‘¢ð‘Ÿð‘’ð‘šð‘— = ð›½0 + ð›½1 ð‘€ð‘Žð‘Ÿð‘”ð‘–ð‘›ð‘Žð‘™ð‘‡ð‘ƒð‘†ð‘šð‘— + ð‘‹ð‘— ð›½ + ðœ€ð‘šð‘—                                   (8)

        Our hypothesis is that ð›½1 > 0 for measures such that a higher score indicates better

performance (most measures). Patient experience, clinical process, and mortality measures are

reported as percentages. Higher scores indicate better performance for most measures.

However, lower values in Patient Safety Composite Score, CLABSI Score, and Medicare-

Spending-per-Beneficiary Ratio indicate better quality or spending. We not only ran the main

model, but also included interactions with whether the hospital is integrated and whether the

hospital is a safety-net hospital.



5. Data

National data

        The main analyses use national data to estimate the effect of a one-decile improvement in

measurement. These calculations do not require individual-level data. Therefore, we can use

data from all hospitals. We used data from the CMS Hospital Compare and Medicare Impact


                                                19
File to identify hospitals participating in the HVBP program in both fiscal year 2015 and 2016.

For each of these 2,972 hospitals, we evaluated hospital-level performance on the spending and

quality measures in the HVBP program using publically available CMS Hospital Compare data

(see Table 3 for summary statistics). Additionally, we used the CMS FY 2016 Final Rule and

Impact File to obtain actual payment adjustments due to the HVBP program and to estimate

case-mix adjusted annual Medicare base payment rates.

       We also used the FY 2016 Impact File to obtain hospital characteristics such as service

regions, urban or rural status, and Medicare dependency. To examine hospital characteristics

such as teaching affiliation and hospital ownership, we augmented the Impact File with the

American Hospital Association Annual Survey from 2013. Teaching affiliation is defined based

on both AHA major and minor teaching hospital status. This include hospitals with approval to

participate in residency or internship training by the Accreditation Council for Graduate Medical

Education, hospitals with medical school affiliation as reported to the American Medical

Association, hospitals that are members of the Council of Teaching Hospitals of the Association

of American Medical Colleges, and hospitals with internship or residency approved by the

American Osteopathic Association.

       Additionally, we examined hospital integration with post-acute care using the FY 2014

Hospital Cost Report Information System. We constructed one measure of integration by

identifying whether an acute hospital owned an inpatient rehabilitation facility (IRF), skilled

nursing facility (SNF), or home health agency (HHA). Within our national sample,

approximately 28 percent of hospitals had a hospital-based IRF, 17 percent with hospital-based

SNF, and 24 percent with hospital-based HHA. A little more than half of all hospitals own at

least one of the three types of hospital-based post-acute care services (52%).



                                                20
        For the analyses that focus on safety-net hospitals, we employed a combined measure

based on two methods used in recent studies as measures of hospital safety-net status (Chatterjee

and Joynt, 2014; Gilman et al., 2014; Gilman et al., 2015; Mohan et al., 2013). One component

of our measure is based on the amount of Medicare uncompensated care (UCC) per claim; the

other is the percentage of DSH. The Medicare DSH percentage is derived from the share of

inpatient days attributable to Medicare patients eligible for Supplemental Security Income (SSI)

and non-Medicare patients eligible for Medicaid. Following FY 2014, Medicareâ€™s DSH

payments are reduced to 25 percent and the remaining 75 percent is transitioned to

uncompensated care. Each Medicare DSH hospital would receive an uncompensated care

payment based on 75 percent of the estimated DSH payment, share of uninsured patients, and a

relative amount of UCC as compared to a national sample of DSH hospitals. Given the

transition to UCC under PPACA, we consider both DSH and UCC as two dimensions of safety-

net status.

        Across these two components, we characterized hospitals as safety-net if they are in the

top quartile of DSH or UCC across our national sample, resulting in a total of 940 safety-net and

2,032 non safety-net hospitals. Generally, safety-net hospitals differ from non safety-net

hospitals in a number of ways. As compared with non safety-net hospitals, approximately 49

percent of safety-net hospitals are teaching affiliated as compared to 32 percent of non safety-net

hospitals. An average, safety-net hospitals are larger in size than non safety-net hospitals in terms

of mean beds per hospital (280 vs. 168 beds) and average number of annual Medicare claims

(3300 vs. 2873). Lastly, fewer safety-net hospitals than non safety-net hospitals received bonuses

of some value under the FY 2015 HVBP program (61 percent vs. 43 percent).




                                                 21
Michigan data

       Some of our analyses require having patient-level Medicare data. For those analyses, we

turn to the state of Michigan, which has 82 hospitals participating in the HVBP program. As

compared to the national sample, Michigan hospitals were similar across a number of dimensions

(see Table 3 for summary statistics). For example, Michigan hospitals were comparable to the

rest of the US on the proportion of hospitals that received HVBP bonuses (51% vs. 56%),

hospital bed counts (median of 181 vs. 146), as well as in the receipt of payments for DSH (mean

26% vs. 29%). Our sample also indicate that Michigan hospitals were more reliant on Medicare

beneficiaries as compared to the rest of the US, with an average of approximately 75% more

Medicare patients per year, and tended to receive fewer Medicare dollars for uncompensated care

(median of $335 per claim vs. $424 per claim). Further, Michigan hospitals tended to be more

integrated than the general US hospital sample.

       To compute the marginal effect of one additional death (for the three specific conditions)

on Medicare payments we need to know both the mortality rate and the number of admissions in

each hospital during the measurement period (October 1, 2012 through June 30, 2013). The

CMS Hospital Compare and Medicare Impact File give the mortality rate for AMI, heart failure,

and pneumonia for each participating Michigan hospital. To compute the marginal effect of one

more death, we also need the denominator. Using the 100% FY 2015 MEDPAR data we

counted the number of patients admitted to each of the 82 hospitals for the three conditions

between October 1, 2013 and June 30, 2013. The final sample has 6,017 admissions for AMI,

9,982 for heart failure, and 8,644 for pneumonia.

       To compute the marginal effect of each patientâ€™s episode payments on the hospitalâ€™s

efficiency score and Medicare payments, we need patient-level episode payments. Fortunately,



                                                  22
we have access to price-standardized episode payments for all Medicare patients in Michigan,

including up to 30 days post discharge. The Michigan episode payments are not risk adjusted,

although the national HVBP spending measure is. We estimated total Medicare episode

payments for each of the Michigan hospitals in our sample for all claims dated between May 1,

2013 and December 31, 2013 (the measurement period for efficiency). Because the HVBP

payment adjustments only affect the Medicare Part A base payment rates, we excluded Medicare

reimbursements for disproportionate share hospital, indirect medical education, and new

technology payments. Only patients with Medicare as the primary payer were included in these

figures. Our sample of Michigan Medicare patients includes 24,643 admissions.



6. Results

Marginal future reimbursement for mortality in Michigan

       The marginal future reimbursement of one additional death ranges widely across the

eligible Michigan hospitals, from $0 to more than a $40,000 penalty (see Figure 1). First, for

roughly one-third of all hospitals, one additional death does not affect marginal future

reimbursement. The specific numbers are 17 hospitals (out of 50) for AMI, 33 out of 73 for

heart failure, and 25 out of 75 for pneumonia. On the other hand, for the two-thirds of hospitals

that do face a penalty, the marginal future reimbursement (negative, a penalty) can be as large as

âˆ’$44,683 for AMI, âˆ’$41,303 for heart failure, and âˆ’$29,345 for pneumonia.

       Michigan hospitals with larger (more negative) marginal future reimbursements, as

defined by hospitals with below-the-mean marginal future reimbursement, have more beds, are

more likely to be integrated, and tend to be safety-net hospitals (see Table 4 for four

representative measure). These hospitals also have greater achievement scores in the middle of


                                                 23
the score distribution, consistent with greater sensitivity to shifts in scoring as compared to

hospitals at the bottom of the performance distribution.



One-decile improvement

       The results of the one-decile improvements show remarkably consistent patterns of wide

heterogeneity, with the largest values being quite substantial (see Figures 2, 3, and 4). These

figures show box and whisker plots, with the lines on the boxes representing the 25th, median,

and 75th percentiles. The whiskers represent 1.5 times the interquartile range. Any observations

outside the whiskers are drawn with a circle.

       We start with the mortality results, which are somewhat comparable to the Michigan

results for a single death (see Figure 2). A large fraction of hospitals nationwide would see no

financial benefit from improving their mortality rate by one decile. For AMI, about two-thirds of

hospitals would get a bonus. For heart failure and pneumonia, this value is over 90 percent. For

hospitals that would receive a bonus, most would receive less than $50,000, but a few would

receive more than $100,000. The other two outcome measures (PSI-90 and CLABSI) have

similar distributions, with approximately one-third of hospitals with zeros and a long right tail

extending past $100,000, to an extreme of more than $200,000.

       A one-decile improvement in the efficiency measure (Medicare Spending Per

Beneficiary, or MSPB) is similarly skewed (see bottom row of Figure 2). There is no financial

payment for 73 out of 2,972 hospitals (2%). The median is around $20,000. The incentive to

improve efficiency by one-decile is as high as $300,000.

       In contrast to the results for the one-decile improvements in outcomes and efficiency

scores, the results for patient experience (see Figure 3) and clinical process of care (see Figure 4)



                                                 24
are much smaller in magnitude. The median values, again shown in box and whisker plots, are

less than $5,000. The upper whisker values are never higher than $20,000. The highest values

were nearly all less than $100,000. As with the other measures, there were sizeable fractions

with zero values.



Heterogeneity in one-decile improvement

       Having shown wide variation in the distribution of incentives from a one-decile

improvement, we next document differences in TPS across different types of hospitals (see

Tables 5A and 5B). Hospitals that are rural, non-teaching, and have relatively few Medicare

admissions face higher incentives than other types of hospitals. Hospitals that are integrated

with SNFs, IRFs, or home health agencies tend to have similar marginal incentives as those that

are non-integrated in terms of TPS change. For the measure of episode spending, integrated

hospitals appear to face slightly smaller incentives than non-integrated hospitals. In terms of

Medicare reimbursement, however, our results indicate that integrated hospitals tend to have

larger total marginal future reimbursements than non-integrated hospitals (see Table 6). There is

no appreciable difference between safety-net and non-safety net hospitals and the marginal

incentives are relatively similar across various parts of the US.

       We also present results that show the technical relationship between improvement and

achievement points on the adjustment factor after a one-decile improvement in measure

performance. The measures generally follow one of two patterns. The first pattern is

exemplified by the Medicare-Spending-per-Beneficiary and overall hospital rating measures (see

Figures 5 and 6). The underlying measures are quite continuous. For this first pattern, hospitals

in the middle of the scoring distribution for both improvement and achievement face a larger



                                                 25
incentive than hospitals at the tail ends of the distribution. Hospitals that are either already

among the best or the worst have little direct financial incentive to improve.

        The second pattern is demonstrated by measures on AMI mortality and beta blocker

during the perioperative period (see Figures 7 and 8), and is consistent with the other patient

experience and clinical measures. The underlying measures have a ceiling effect, that is, a large

group of hospitals that achieve the maximum score and cannot improve. For this second pattern,

hospitals tend to have more to gain from a one-decile improvement when performance across

both improvement and achievement is low.



Change in TPS

        The overall results showing the relationship between the marginal incentive from a one-

decile improvement in a measure and its year-to-year change in measure performance are

generally consistent with our hypothesis (see Table 7). The model predicts that higher marginal

benefits from performance improvements should induce greater improvement in performance

over time. The first 15 measures are defined so that a higher number indicates improvement in

performance, while the last three (patient safety composite score, CLABSI, and efficiency) are

all defined so that lower scores are preferred. Of these, seven are statistically significant and of

the expected sign, two are statistically significant and of the opposite sign; the rest are not

statistically significant.

        For most measures integrated hospitals perform at least as well as non-integrated

hospitals, with the exception of two process measures, where the coefficients are the wrong sign

(see Table 8). There appears to be no difference in response across integrated and non-integrated

hospitals for patient experience measures. Our results show that integrated hospitals are



                                                  26
associated with improvement on the spending, CLABSI, and Beta Blocker During Perioperative

Period measures as compared to non-integrated hospitals.

       The patterns across safety-net hospitals and non-safety-net hospitals are broadly

consistent in that the interaction effects show that safety-net hospitals are generally not

statistically significantly different from non safety-net hospitals (see Table 8). We find that

safety-net hospitals had a stronger response to one patient experience measure and one clinical

process measure as compared to non safety-net hospitals, and a stronger but worse performance

on AMI mortality and Postoperative Urinary Catheter Removal measure.



Limitations

       The analyses are limited by lack of information in two areas. We only have individual-

level data on the measures for mortality in Michigan, so can only calculate the patient-level

marginal future reimbursement for the three mortality measures. Fortunately, the one-decile

improvement measures give a good sense of the distribution of incentives across hospitals

(although not within hospitals). We also do not have information on the cost of modest

improvements in any of the measures, either the level or their distributions. A full examination

of whether hospitals improve their HVBP measures would not only include the financial

incentives of improvement (as we did) but also the cost of improvement (which is unknown).

We have no reason to believe that the actual costs are correlated with the incentives, meaning

that our estimates are probably unbiased. Finally, the details of the HVBP program have

changed every single year. Therefore, while our general theoretical points stand, the specifics of

the estimates and distributions are specific to the years studied. We hope that our analyses will

help CMS continue to improve their design of the HVBP program in the future.



                                                 27
7. Conclusion

       Our study has produced a number of interesting methodological and policy-relevant

findings. In the methodological area, we have three notable conclusions. First, we described

how a hospitalâ€™s reimbursement from each Medicare patient consists not only of the payment for

the index hospitalization (primarily the DRG payment), but also the marginal future

reimbursement from the patientâ€™s effect on quality and spending measures in the HVBP pay-for-

performance program. Second, we show that these marginal future reimbursements vary both

within hospital and across hospitals and that they sometimes, but not always, create incentives to

improve. Third, we show that for many measures, hospitals with larger financial incentives did

improve their performance more than hospitals with smaller financial incentives.

       Although studies have documented the lack of significant improvements in overall

average quality by hospitals participating in HVBP (Ryan et al., 2015; Figueroa et al., 2016), this

is the first evaluation of the program to consider the distribution of incentives based on marginal

improvements in performance. Our results are consistent with the prior findings in that overall

changes in measures are small or zero, yet we show that they are substantial for some hospitals,

in part because of the wide variation in the distribution of the size of the incentives.

       In the area of policy, we also have three noteworthy findings. First, the incentives in the

HVBP program are complicated, but understanding them is essential for understanding how to

modify and improve the program going forward. CMS may want to change the formulas to

create positive incentives for a larger percentage of hospitals. Second, our results find that

integrated hospitals are more responsive to the incentive for the efficiency measure (and other

measures) than non-integrated hospitals. Integrated hospitals may be more efficient at improving



                                                  28
quality and holding down costs post-discharge, and in the long run more hospitals may become

more integrated. Third, our research also has implications for the broader literature on the value

of information and the importance of health information technology. If a hospital knew â€” in

real time â€” the marginal future reimbursement for an individual patient for specific measures, it

could better optimize how to improve its bottom line while improving value of care.




                                                29
References

Burwell, S.M., 2015. Setting value-based payment goals â€“ HHS efforts to improve U.S. health
      care. New England Journal of Medicine 372 (10), 897-899.

Centers for Medicare & Medicaid Services, 2012a. Frequently asked questions hospital
      value-based purchasing program.

Centers for Medicare & Medicaid Services, Federal Register, 2012b. Medicare program;
      hospital inpatient prospective payment systems for acute care hospitals and the long-term
      care hospital prospective payment system and fiscal year 2013 rates; hospitalsâ€™ resident
      caps for graduate medical education payment purposes; quality reporting requirements
      for specific providers and for ambulatory surgical centers, Final Rule, 77, 53257-53750.

Centers for Medicare & Medicaid Services, 2013a. Hospital value-based purchasing program
      fact sheet.

Centers for Medicare & Medicaid Services, 2013b. National provider call: Hospital value-
      based purchasing.

Chatterjee, P., Joynt, K.E., 2014. Do cardiology quality measures actually improve patient
      outcomes? Journal of the American Heart Association, 3 (1).

Chen, C., Ackerly, D., 2014. Beyond ACOs and bundled payments: Medicareâ€™s shift toward
      accountability in fee-for-service. Journal of the American Medical Association 311 (7),
      673-674.

Das, A., Norton, E.C., Miller, D.C., Chen, L.M., 2016a. Spending in the post-acute care
       setting accounts for a sizeable portion of spending associated with a hospitalization
       episode. Journal of the American Medical Association Internal Medicine 176 (1), 117-
       119.

Das, A., Norton, E.C., Miller, D.C., Ryan, A.M., Birkmeyer, J.D., Chen, L.M., 2016b.
       Adding a spending metric to Medicareâ€™s value-based purchasing program rewarded low-
       quality hospitals. Health Affairs 35(5), 898-906.

Figueroa, J.F., Tsugawa, Y., Zheng, J., Orav, E.J., Jha, A.K. 2016. Association between the
      value-based purchasing pay for performance program and patient mortality in US
      hospitals: observational study. BMJ 353, i2214.

Fryer, R.G., 2013. Teacher incentives and student achievement: Evidence from New York City
       public schools. Journal of Labor Economics 31(2), 373-407.

Gilman, M., Adams, E.K., Hockenberry, J.M., Wilson, I.B., Milstein, A.S., Becker, E.R.,
      2014. California safety-net hospitals likely to be penalized by ACA value, readmission,
      and meaningful-use programs. Health Affairs (Project Hope) 33 (8), 1314-1322.

                                              30
Gilman, M., Hockenberry, J.M., Adams, E.K., Milstein, A.S., Wilson, I.B., Becker, E.R.,
      2015. The financial effect of value-based purchasing and the hospital readmissions
      reduction program on safety-net hospitals in 2014: A cohort study. Annals of Internal
      Medicine 163 (6), 427-436.

Jacob, B.A., 2005. Accountability, incentives and behavior: The impact of high-stakes testing in
       the Chicago Public Schools. Journal of Public Economics 89 (5-6), 761-796.

Holmstrom, B., P. Milgrom, 1991. Multitask Principal-Agent Analyses: Incentive Contracts,
      Asset Ownership, and Job Design. Journal of Law, Economics & Organization 7 (SI),
      24âˆ’52.

Mohan, A., Grant, J., Batalden, M., McCormick, D., 2013. The health of safety net hospitals
     following Massachusetts health care reform; Changes in volume, revenue, costs, and
     operating margins from 2006 to 2009. International Journal of Health Services 43, 321-
     335.

Neal, D., 2011. The Design of Performance Pay in Education. Handbook of Economics of
       Education. Volume 4. Elsevier North Holland.

Quality Net, 2015. Medicare spending per beneficiary (MSPB) measure overview.

Ryan, A.M., Burgess Jr, J.F., Pesko, M.F., Borden, W.B., Dimick, J.B., 2015. The early
      effects of Medicareâ€™s mandatory hospital pay-for-performance program. Health Services
      Research 50:1, 81-97.




                                              31
Table 1
HVBP domain weights by fiscal year
Domains                       2013   2014   2015   2016
Patient Experience of Care    30%    30%    30%    25%
Clinical Process of Care      70%    45%    20%    10%
Outcomes                        -    25%    30%    40%
Efficiency                      -      -    20%    25%




                                     32
Table 2
HVBP domain measures in FY 2015
Patient Experience of Care Domain (8)
   Nurse Communication
   Doctor Communication
   Hospital Staff Responsiveness
   Pain Management
   Medicine Communication
   Hospital Cleanliness & Quietness
   Discharge Information
   Overall Hospital Rating
Clinical Process of Care Domain (12)
   Fibrinolytic Therapy Received within 30 minutes of Hospital Arrival â€ â€ 
   Primary PCI Received within 90 minutes of Hospital Arrival â€ 
   Heart Failure Discharge Instructions â€ 
   Blood Cultures Performed in the ED Prior to Initial Antibiotic Received in
   Hospital â€ 
   Initial Antibiotic Selection for CAP in Immunocompetent Patient â€ â€ â€ 
   Prophylactic Antibiotic Received within One Hour Prior to Surgical Incision â€ 
   Prophylactic Antibiotic Selection for Surgical Patients
   Prophylactic Antibiotics Discontinued within 24 hours after Surgery â€ â€ â€ 
   Cardiac Surgery Patients with Controlled 6 AM Post-Operative Serum Glucose â€ 
   Postoperative Urinary Catheter Removal on Postoperative Day 1 or 2
   Surgery Patients on a Beta Blocker Prior to Arrival That Received a Beta Blocker
   During the Perioperative Period
   Surgery Patients Who Received Appropriate Venous Thromboembolism
   Prophylaxis within 24 Hours
Outcomes Domain (5)
   Acute Myocardial Infarction 30-day Mortality Rate
   Heart Failure 30-Day Mortality Rate
   Pneumonia 30-Day Mortality Rate
   Patient Safety for Select Indicators Composite Score (AHRQ PSI-90)
   Central Line-Associated Bloodstream Infection (CLABSI) Score
Efficiency Domain (1)
   Medicare-Spending-per-Beneficiary
Notes: â€  Measures that were removed from HVBP FY 2016
â€ â€  Measure removed from analysis due to small sample size
â€ â€ â€  Measure removed from analysis due to data errors




                                             33
Table 3
Hospital characteristics
                                     National   Michigan
                                     Sample     Subsample
Hospitals, N                              2,972         82
HVBP
   Positive FY 2015 HVBP Bonus, %                55     51
Ownership, %
   For-profit                                    23      6
   Not-for-profit                                63     85
   Government                                    14      9
Region, %
   Northeast                                     16      -
   Midwest                                       24    100
   South                                         40      -
   West                                          19      -
Geographic Core-based Statistical Area, %
   Large Urban                                   41     37
   Other Urban                                   35     37
   Rural                                         24     27
Teaching and Medicare
   Teaching affiliated, %                      38        59
   Medicare Days, %                            38        44
   Medicare Admissions, mean                3,008     4,487
Hospital Integration
   Integrated SNF, HHA, or IRF, %                52     72
Safety-net Hospital
   Safety-net status, %                       32        15
   Uncompensated Care per Claim              702       395
   Disproportionate Share, %                  29        26




                                            34
Table 4
Payment Loss from one additional mortality by hospital characteristics, Michigan

                                                                   Bed    PAC
                         Measure    Improvement     Achievement    Size   Integration      Safety-Net
                    N    (mean)     Score (mean)    Score (mean)   (mean) (%)              (%)
Outcome: AMI Mortality
  Total              50 85.6        4.2              5.3            341     72             20
  $0                 17 85.2        3.2              3.5            358     76             24
  $0 to                                                                     68             11
  âˆ’$17,654           19 85.7        4.4              5.5            282
  > âˆ’$17,653         14 85.9        5                7.1            399     71             29
Outcome: Heart Failure Mortality
  Total              73 88.0        1.5              2.2            262     71             15
  $0                 33 87.1        0.3              0.6            245     70             6
  $0 to âˆ’$9,119 24 88.3             1.8              2.2            227     71             25
  > âˆ’$9,119          16 89.2        3.8              5.5            352     75             19
Outcome: Pneumonia Mortality
  Total              75 88.9        3.3              4.1            255     72             15
  $0                 25 87.6        1.1              1.2            246     72             12
  $0 to              31 89.5        5.0              5.2            197     68             10
  âˆ’$10,804
  > âˆ’$10,804         19 89.6        3.5              6.0            363     79             26
         â€  Lower MSPB score indicates better performance
         For each measure, measures specific information are presented for all hospitals for which the
         measure is relevant, hospitals for which a decile improvement yielded no change in annual
         Medicare payments, hospitals for which a decile improvement yielded some change in
         annual Medicare payment that is less than or equal to the mean payment amount, and
         hospitals for which a decile improvement yielded a change in payment that is greater than
         the mean payment amount.




                                            35
Table 5A
Mean change in TPS from one-decile improvement, by hospital characteristics
                                  Experience: Process: Outcome:
                                  Hospital    Beta     AMI          Efficiency:
                                  Rating      Blocker  Mortality    MSPB
All Hospitals in Measure          0.50        0.41     0.75         3.06
Ownership
   For-profit                     0.48        0.47     0.71         3.27
   Not-for-profit                 0.49        0.39     0.75         2.91
   Government                     0.54        0.44     0.85         3.39
Region
   Northeast                      0.49        0.42     0.71         2.72
   Midwest                        0.46        0.36     0.74         3.09
   South                          0.52        0.43     0.81         3.02
   West                           0.49        0.45     0.71         3.38
Geographic Core-based Statistical Area
   Large Urban                    0.46        0.40     0.72         2.79
   Other Urban                    0.45        0.40     0.79         2.93
   Rural                          0.61        0.47     0.75         3.70




                                     36
Table 5B
Mean change in TPS from one-decile improvement, by hospital characteristics
                                 Experience: Process:    Outcome:
                                 Hospital    Beta        AMI         Efficiency:
                                 Rating      Blocker     Mortality MSPB
Teaching affiliation
  Affiliated                     0.45        0.38        0.75        2.64
  Not Affiliated                 0.52        0.44        0.76        3.32
Percent Medicare Days
  < Mean Medicare Days           0.48        0.41        0.77        3.01
  â‰¥ Mean Medicare Days           0.51        0.42        0.74        3.11
Medicare Admissions per Year
  < Mean Medicare Admissions     0.53        0.46        0.73        3.48
  â‰¥ Mean Medicare Admissions     0.43        0.35        0.76        2.36
Hospital Integration
  PAC Integration                0.49        0.40        0.77        2.97
  No PAC Integration             0.50        0.44        0.73        3.16
Safety-Net Status, UCC or DSH
  Safety-Net                     0.53        0.44        0.79        3.03
  Non Safety-Net                 0.48        0.40        0.74        3.08
 FY 2015 HVBP Bonus
  Downward Adjustment            0.49        0.47        0.88        2.60
  Upward Adjustment              0.50        0.37        0.60        3.43




                                     37
Table 6
Payment change from one-decile improvement by hospital characteristics

                                                                                  PAC
                            Measure Improvement Achievement Bed Size Integration
                  N         (mean)     Score (mean) Score (mean) (mean)           (%)
Experience: Hospital Rating
   Total            2,937 69.9         1.6             2.7            206         52
   $0                 149 85.9         6.0             9.1            97          19
   $0 â€“ $5,070      1,884 69.0         1.3             2.2            139         50
   > $5,070           904 69.1         1.3             2.8            362         63
Process: Beta Blocker
   Total            2,715 97.0         3.8             4.8            218         53
   $0                 772 99.1         6.0             9.5            166         46
   $0 â€“ $5,863      1,261 95.9         3.4             2.8            163         52
   > $5,863           682 96.8         2.2             3.4            378         64
Outcome: AMI Mortality
   Total            1,485 85.5         4.8             5.3            305         62
   $0                 444 86.8         8.8             9.6            324         64
   $0â€“$18,515         704 85.3         4.0             4.3            227         58
   > $18,515          337 84.3         1.4             1.8            441         68
Efficiency: MSPBâ€ 
   Total            2,962 0.99         0.88            1.88           204         52
   $0                  73 0.85         6.05            7.81           112         38
   $0â€“$27,853        1907 0.98         0.97            1.89           127         47
   > $27,853          982 1.00         0.42            1.41           362         63
â€  Lower MSPB score indicates better performance
For each measure, measures specific information are presented for all hospitals for which the
measure is relevant, hospitals for which a decile improvement yielded no change in annual
Medicare payments, hospitals for which a decile improvement yielded some change in
annual Medicare payment that is less than or equal to the mean payment amount, and
hospitals for which a decile improvement yielded a change in payment that is greater than
the mean payment amount.




                                              38
Table 7
FY 2016 measure change from one-decile measure improvement
                                                Mean       Coeff. (SE)
Patient Experience of Care Domain
   Nurse Communication                          78.03      -0.34**
                                                           (0.16)
   Doctor Communication                         80.55       0.31***
                                                           (0.12)
   Hospital Staff Responsiveness                65.36      -0.04
                                                           (0.19)
   Pain Management                              70.15       0.39**
                                                           (0.17)
   Medicine Communication                       63.07       0.36
                                                           (0.21)
   Hospital Cleanliness & Quietness             65.69      -0.12
                                                           (0.13)
   Discharge Information                        85.57       0.66***
                                                           (0.13)
   Overall Hospital Rating                      69.89       0.66***
                                                           (0.19)
Clinical Process of Care Domain
   Prophylactic Antibiotic Selection            98.74       1.04***
                                                           (0.14)
   Urinary Catheter Removal                     96.90      -0.19
                                                           (0.31)
   Beta Blocker During Perioperative Period     97.03       0.26
                                                           (0.18)
   VTE Prophylaxis Within 24 Hours              97.60       1.79***
                                                           (0.10)
Outcomes Domain
   AMI Survival Rate (1 â€“ Mortality Rate)       85.53       0.081***
                                                           (0.026)
   HF Survival Rate (1 â€“ Mortality Rate)        87.94       0.026
                                                           (0.017)
   PN Survival Rate (1 â€“ Mortality Rate)        88.35      -0.022
                                                           (0.020)
   Patient Safety Composite Score               0.50       -0.0017
                                                           (0.0020)
   CLABSI Score                                 0.52       -0.018
                                                           (0.013)
Efficiency Domain
   Medicare-Spending-per-Beneficiary Ratio      0.99        0.00103***
                                                           (0.00036)
** p<0.05
***p<0.01
These results report the measure averages in FY 2015, and the

                                           39
coefficient and its standard error from regressing measure rate
differences from FY 2015 to FY 2016 on marginal incentive (effect of
one-decile improvement on Total Performance Score). Patient
experience, clinical process, and mortality measures are reported as
percentages, and higher scores indicate better performance. Lower
values in Patient Safety Composite Score, CLABSI Score, and
Medicare-Spending-per-Beneficiary Ratio indicate better quality.




                                           40
Table 8
FY 2016 measure change from one-decile measure improvement conditional on
integration and safety-net status
                                         Constant      Integrated       Safety-Net
                                         term (SE)      (SE)            (SE)
Patient Experience of Care Domain
   Nurse Communication                   -0.29          -0.14            -0.05
                                         (0.24)         (0.32)           (0.34)
   Doctor Communication                   0.27          -0.07             0.22
                                         (0.17)         (0.23)           (0.25)
   Hospital Staff Responsiveness         -0.28          -0.24             0.88**
                                         (0.29)         (0.38)           (0.39)
   Pain Management                        0.42          -0.41             0.49
                                         (0.25)         (0.33)           (0.36)
   Medicine Communication                 0.86***       -0.51            -0.76
                                         (0.32)         (0.42)           (0.44)
   Hospital Cleanliness & Quietness       0.11          -0.31            -0.21
                                         (0.20)         (0.24)           (0.25)
   Discharge Information                  0.81***        0.07            -0.41
                                         (0.19)         (0.21)           (0.21)
   Overall Hospital Rating                0.35           0.32             0.46
                                         (0.29)         (0.36)           (0.37)
Clinical Process of Care Domain
   Prophylactic Antibiotic Selection for  0.88***        0.40             0.12
   Surgical Patients                     (0.18)         (0.22)           (0.21)
   Postoperative Urinary Catheter         0.72**        -1.14***         -1.72***
   Removal                               (0.36)         (0.40)           (0.41)
   Beta Blocker During Perioperative     -0.22           0.79**           0.92***
   Period                                (0.22)         (0.32)           (0.35)
    Surgery Patients Who Received         2.00***       -0.34**          -0.27
   Appropriate VTE                       (0.13)         (0.17)           (0.16)
Outcomes Domain
   Acute Myocardial Infarction 30-day     0.091**        0.040           -0.104**
   Mortality Rate                        (0.037)        (0.040)          (0.041)
   Heart Failure 30-Day Mortality Rate    0.012          0.052            0.035
                                         (0.028)        (0.034)          (0.047)
   Pneumonia 30-Day Mortality Rate       -0.012         -0.049            0.047
                                         (0.030)        (0.036)          (0.039)
   Patient Safety for Select Indicators  -0.0001         0.0026           0.0011
   Composite Score                       (0.0026)       (0.0026)         (0.0027)
   Central Line-Associated Bloodstream    0.010         -0.050**          0.003
   Infection Score                       (0.021)        (0.022)          (0.022)
Efficiency Domain
   Medicare-Spending-per-Beneficiary      0.00186***    -0.00269***       0.00087
   Ratio                                 (0.00050)      (0.00069)        (0.00074)
** p<0.05

                                       41
***p<0.01
These results report the coefficients and standard errors from 18 regressions: effect of decile
improvement on TPS with respect to measure rate change from FY15 to FY16 when the hospitals
are not integrated and not safety-net, the difference in effect when the hospitals are integrated and
non-safety-net, and the difference in effect when the hospitals are not integrated and safety-net.
Patient experience, clinical process, and mortality measures are reported as percentages, and
higher scores indicate better performance. Lower values in Patient Safety Composite Score,
CLABSI Score, and Medicare-Spending-per-Beneficiary Ratio indicate better quality.




                                              42
Figure 1.




Figure 2.




            43
Figure 3.




Figure 4.



            44
Figure 5.




Figure 6.




            45
Figure 7.




Figure 8.




            46
